Ms Huai-Wen Liang
E-Da hospital, Kaohsiung (Taiwan)
Baseline characteristics, treatment dosage, and clinical outcomes of post-acute HFrEF patients initiated with Sacubitril/Valsartan
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
ESC 365 is supported by
